Horizon Pharma Plc (HZNP) Shareholder Beach Point Capital Management LP Decreased Its Holding

August 11, 2017 - By Migdalia James

Investors sentiment decreased to 1.02 in 2016 Q4. Its down 0.44, from 1.46 in 2016Q3. It dropped, as 40 investors sold HZNP shares while 69 reduced holdings. 44 funds opened positions while 67 raised stakes. 134.44 million shares or 0.39% more from 133.91 million shares in 2016Q3 were reported. Vanguard Group invested in 0.01% or 12.24M shares. First Dallas accumulated 24,410 shares. Wolverine Asset Management Llc holds 0% or 1,400 shares. Group Inc Inc One Trading Lp stated it has 229,284 shares. Hap Trading Limited Liability Company holds 0.04% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP) for 50,440 shares. Fiera Capital Corp holds 0.13% or 1.42 million shares in its portfolio. Kingdon Cap Mgmt Ltd Liability Company invested in 6.68 million shares. Iguana Ltd Liability Company holds 50,000 shares. Gradient Invests Ltd Liability owns 15,283 shares or 0.02% of their US portfolio. Millennium Mgmt Limited reported 0% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP). California State Teachers Retirement System holds 0.01% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP) for 332,733 shares. Raymond James Associate has invested 0.01% in Horizon Pharma PLC (NASDAQ:HZNP). Blackrock owns 19,337 shares. Federated Investors Pa invested in 0% or 57,302 shares. Walleye Trading Ltd Co, Minnesota-based fund reported 22,088 shares.

Since February 28, 2017, it had 1 buy, and 1 sale for $414,996 activity. GREY MICHAEL G also bought $94,800 worth of Horizon Pharma PLC (NASDAQ:HZNP) shares. $509,796 worth of Horizon Pharma PLC (NASDAQ:HZNP) shares were sold by Carey Robert.

Carl Goldsmith decreased its stake in Horizon Pharma Plc (HZNP) by 81.63% based on its latest 2016Q4 regulatory filing with the SEC. Beach Point Capital Management Lp sold 949,207 shares as the company’s stock declined 38.11% while stock markets rallied. The hedge fund run by Carl Goldsmith held 213,544 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $3.46 million, down from 1.16 million at the end of the previous reported quarter. Beach Point Capital Management Lp who had been investing in Horizon Pharma Plc for a number of months, seems to be less bullish one the $1.98 billion market cap company. The stock rose 4.81% or $0.56 reaching $12.1. About 4.23 million shares traded or 3.42% up from the average. Horizon Pharma PLC (NASDAQ:HZNP) has declined 28.13% since August 11, 2016 and is downtrending. It has underperformed by 44.83% the S&P500.

Beach Point Capital Management Lp, which manages about $8.09 billion and $221.74 million US Long portfolio, upped its stake in Mgm Resorts International (NYSE:MGM) by 295,230 shares to 1.80 million shares, valued at $51.78 million in 2016Q4, according to the filing.

More notable recent Horizon Pharma PLC (NASDAQ:HZNP) news were published by: Nasdaq.com which released: “Can Horizon Pharma (HZNP) Spring a Surprise in Q2 Earnings?” on July 31, 2017, also 247Wallst.com with their article: “Horizon Pharma Wins Big in Q2” published on August 07, 2017, Nasdaq.com published: “Horizon Pharma plc Launches CGD Connectionsâ„¢ to Deliver Support and Resources …” on July 25, 2017. More interesting news about Horizon Pharma PLC (NASDAQ:HZNP) were released by: Fool.com and their article: “Why Horizon Pharma plc Stock Is Crashing Today” published on May 08, 2017 as well as Globenewswire.com‘s news article titled: “Horizon Pharma plc Announces Four Poster Presentations on PROCYSBI …” with publication date: July 14, 2017.

Horizon Pharma PLC (NASDAQ:HZNP) Ratings Coverage

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Horizon Pharma had 37 analyst reports since September 9, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of HZNP in report on Tuesday, June 27 with “Buy” rating. The firm has “Buy” rating given on Monday, November 28 by Citigroup. UBS maintained Horizon Pharma PLC (NASDAQ:HZNP) rating on Tuesday, August 8. UBS has “Buy” rating and $1600 target. On Friday, October 9 the stock rating was initiated by Mizuho with “Buy”. Piper Jaffray maintained Horizon Pharma PLC (NASDAQ:HZNP) rating on Tuesday, July 25. Piper Jaffray has “Buy” rating and $1700 target. The rating was maintained by Mizuho with “Hold” on Monday, August 7. Citigroup maintained the stock with “Neutral” rating in Tuesday, August 9 report. Jefferies initiated Horizon Pharma PLC (NASDAQ:HZNP) on Tuesday, January 19 with “Buy” rating. The rating was maintained by Mizuho on Tuesday, February 28 with “Buy”. Mizuho maintained Horizon Pharma PLC (NASDAQ:HZNP) on Tuesday, November 8 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.